6
Oct
2026
SWISS PARENTERALS LIMITED
Exhibitor at CPHI Milan 2026 stand 14D2, Finished Dosage & Formulation
About Us
Categories
-
Country/Region:India
-
On CPHI since:2015
-
Certificates:5
-
Employees:500 - 999
Company types
Primary activities
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 14D2, Finished Dosage & Formulation
Products Featured at CPHI Milan 2026
-
Product Aztreonam Injection
Aztreonam Injection -
Product ceftazidime/avibactam
(2g/0.5g)/vial: 2.5gEquivalent to 2.635 grams of ceftazidime pentahydrate/sodium carbonate powder and 0.551 grams of avibactam sodium -
Product Ferric carboxymaltose injection
Ferric carboxymaltose injection -
Product Semaglutide injection
Semaglutide injection is used to treat type 2 diabetes. It is used together with diet and exercise to help control your blood sugar. This medicine is also used to lower the risk of heart attack, stroke, or death in patients with type 2 diabetes, obesity, and heart or blood vessel disease. It is also used t... -
Product Phenobarbiton tablets b.p
SWISS PARENTERALS PVT LTD offers wide range of prodcuts which includes phenobarbiton tablets b.p. Packaging: 60 mg. Contact us for more information.



